Camlin Fine Sciences Promoter Declares No Share Encumbrance for FY26

1 min read     Updated on 30 Apr 2026, 10:58 AM
scanx
Reviewed by
Naman SScanX News Team
AI Summary

Infinity Portfolio Holdings, the promoter of Camlin Fine Sciences Ltd., has submitted a regulatory declaration confirming no encumbrance on company shares for the financial year ended March 31, 2026. The declaration was filed pursuant to SEBI Regulation 31(4) and submitted to NSE, BSE, and company officials, maintaining compliance with transparency requirements.

powered bylight_fuzz_icon
39071251

*this image is generated using AI for illustrative purposes only.

Infinity Portfolio Holdings, the promoter of Camlin Fine Sciences Ltd., has submitted a regulatory declaration confirming no encumbrance on the company's shares for the financial year ended March 31, 2026. The declaration was filed on April 02, 2026, in compliance with SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Regulatory Declaration Details

The declaration was submitted pursuant to Regulation 31(4) of the SEBI Takeover Regulations by Infinity Portfolio Holdings, which operates through Vistra Alternative Investments (Mauritius) Limited. The document confirms that the promoter has not created any encumbrance on shares held directly or indirectly, beyond those previously disclosed.

Parameter: Details
Declaration Date: April 02, 2026
Financial Year: Ended March 31, 2026
Regulation: SEBI Regulation 31(4)
Promoter Entity: Infinity Portfolio Holdings
Signatory: Shewinrao Ladkoo, Director
Operating Address: Vistra Alternative Investments (Mauritius) Limited

Compliance and Disclosure

The declaration was simultaneously submitted to multiple regulatory bodies and company officials to ensure comprehensive compliance. The promoter entity confirmed that no new encumbrances were created on company shares during the specified financial year, maintaining transparency in shareholding patterns. The document was signed by Shewinrao Ladkoo, Director, from the Ebene, Mauritius office.

Submission Recipients

The regulatory filing was addressed to multiple stakeholders as part of standard compliance requirements:

Recipient: Details
NSE: National Stock Exchange of India Ltd. (Symbol: CAMLINFINE)
BSE: BSE Limited (Scrip Code: 532834)
Internal: Audit Committee of Camlin Fine Sciences Ltd.
Company: Company Secretary of Camlin Fine Sciences Ltd.

This declaration represents standard regulatory compliance for promoter entities, ensuring stakeholders remain informed about any changes in share encumbrance status. The submission maintains the company's adherence to SEBI's transparency requirements under the takeover regulations.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.32%+18.62%+20.14%-36.95%-22.16%-17.27%

Will Infinity Portfolio Holdings consider increasing its stake in Camlin Fine Sciences now that shares remain unencumbered?

How might this clean shareholding status impact Camlin Fine Sciences' ability to attract new strategic investors or partnerships?

Could the unencumbered share status signal potential corporate restructuring or divestment plans by the promoter group?

Camlin Fine Sciences Promoter Infinity Direct Holdings Declares No Share Encumbrance for FY26

1 min read     Updated on 29 Apr 2026, 03:21 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Infinity Direct Holdings submitted a regulatory declaration confirming no encumbrance on Camlin Fine Sciences shares for FY26. The filing was made pursuant to SEBI Takeover Regulations and authorized by Ahmad Tariq Hossanee from their Mauritius office.

powered bylight_fuzz_icon
38362544

*this image is generated using AI for illustrative purposes only.

Camlin Fine Sciences received a regulatory declaration from its promoter Infinity Direct Holdings regarding share encumbrance status for the financial year ended March 31, 2026. The declaration, dated April 2, 2026, was filed in compliance with SEBI's substantial acquisition and takeover regulations.

Regulatory Declaration Details

Infinity Direct Holdings submitted the declaration pursuant to Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing confirms that the promoter has not created any encumbrance on company shares during the specified period.

Parameter: Details
Filing Date: April 2, 2026
Regulation: SEBI Takeover Regulations 31(4)
Financial Year: Ended March 31, 2026
Promoter Entity: Infinity Direct Holdings
Filing Location: Mauritius

Declaration Statement

The promoter declared that no encumbrance was made on shares held directly or indirectly, other than those already disclosed during the financial year ended March 31, 2026. This statement provides transparency regarding the promoter's shareholding status and any potential restrictions on share transfers.

Corporate Address and Authorization

Infinity Direct Holdings operates from the 6th Floor, Two Tribeca, Tribeca Central, Trianon 72261, Mauritius. The declaration was authorized by Ahmad Tariq Hossanee, Director of Infinity Direct Holdings, serving as the authorized signatory for this regulatory filing.

Contact Details: Information
Address: 6th Floor, Two Tribeca, Tribeca Central
Location: Trianon 72261, Mauritius
Phone: +230 404 3900
Fax: +230 454 6824
Authorized Signatory: Ahmad Tariq Hossanee, Director
Document ID: A2A8B87B-DA51-4CD6-BC0C-E0874C8E4EB7

Regulatory Compliance

The declaration was submitted to ensure comprehensive disclosure and regulatory compliance. The filing serves as an official record for stakeholders and provides transparency about the promoter's share encumbrance status for the concluded financial year. The document was copied to the Company Secretary of Camlin Fine Sciences Limited at their Mumbai office located at 2nd floor, In G.S. Point, CST Road, Kalina, Santacruz (East), Mumbai 400 098.

Historical Stock Returns for Camlin Fine Sciences

1 Day5 Days1 Month6 Months1 Year5 Years
+3.32%+18.62%+20.14%-36.95%-22.16%-17.27%

Will Camlin Fine Sciences' promoter maintain this zero-encumbrance status in FY2027, or are there plans for future pledging arrangements?

How might this clean shareholding status impact Camlin Fine Sciences' ability to pursue strategic acquisitions or expansion plans?

Could this declaration signal potential changes in Infinity Direct Holdings' investment strategy or exit timeline for Camlin Fine Sciences?

More News on Camlin Fine Sciences

1 Year Returns:-22.16%